Liabilities / Assets
Score unavailable
Liabilities-to-assets requires both liabilities and assets on this filing.
Melanoma Research Foundation
990 • Fiscal year 2021 • EIN 80-0671049
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
No value available
Liabilities / Revenue
56th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
39th percentile
Higher net margin than 39% of similar nonprofits.
Top Officer Pay
77th percentile
Higher top officer pay than 77% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
2nd percentile
Faster asset growth than 2% of similar nonprofits.
Revenue Growth
32nd percentile
Faster revenue growth than 32% of similar nonprofits.
Balance Sheet
Assets
Down$0
Down $558,333 (-100%) from 2020
Net Assets
Down$0
Down $474,750 (-100%) from 2020
Liabilities
Down$0
Down $83,583 (-100%) from 2020
Revenue And Expenses
Revenue
Down$320,000
Down $70,534 (-18%) from 2020
Expenses
Down$314,821
Down $64,722 (-17%) from 2020
Net Income
Down$5,179
Down $5,812 (-53%) from 2020
Historical Trend
Jump To
Filing Snapshot
- Filing Period
- Apr 1, 2020 to Mar 31, 2021
- Signed
- Jan 24, 2022
- Return Version
- 2020v4.1
- Gross Receipts
- $320,000
Mission and Program Overview
Mission
The mission of the melanoma research foundation breakthrough consortium, inc. (the consortium) is to accelerate the research and development of the most promising therapeutics in melanoma in order to deliver curative options to patients. The consortium will develop collaborative, multi-sector partnerships across the breadth of melanoma disciplines - basic, translational and clinical science - to expedite development of combinations of therapies as well as novel single agents; support pre-clinical research to facilitate rational combinations; create a virtual annotated specimen biorepository; and identify biomarkers that have prognostic and predictive value or value as a new therapeutic target.
Supports clinical trials, drug develop. & research relating to treatment & prevention of melanoma.
Balance Sheet Detail
| Line | Beginning | End | Change |
|---|---|---|---|
| Assets | |||
| Cash and Non-Interest-Bearing Accounts | $508,321 | $0 | ▼ $508,321 |
| Prepaid Expenses and Deferred Charges | $29,478 | $0 | ▼ $29,478 |
| Savings and Temporary Cash Investments | - | $0 | - |
| Accounts Receivable | - | $0 | - |
| Other Notes and Loans Receivable, Net | - | $0 | - |
| Pledges and Grants Receivable | - | $0 | - |
| Receivable From Disqualified Prsn | - | $0 | - |
| Receivables From Officers Etc | - | $0 | - |
| Investments Other Securities | - | $0 | - |
| Investments Program Related | - | $0 | - |
| Investments in Publicly Traded Securities | - | $0 | - |
| Land, Buildings, and Equipment, Net | - | $0 | - |
| Intangible Assets | - | $0 | - |
| Inventories for Sale or Use | - | $0 | - |
| Total Assets | $558,333 | $0 | ▼ $558,333 |
| Other Assets Total | $20,534 | $0 | ▼ $20,534 |
| Liabilities | |||
| Grants Payable | $75,000 | $0 | ▼ $75,000 |
| Accounts Payable and Accrued Expenses | $8,583 | $0 | ▼ $8,583 |
| Total Liabilities | $83,583 | $0 | ▼ $83,583 |
| Net Assets / Fund Balance | |||
| Net Assets With Donor Restrictions | $400,150 | $0 | ▼ $400,150 |
| Net Assets Without Donor Restrictions | $74,600 | $0 | ▼ $74,600 |
| Total Net Assets Fund Balance | $474,750 | $0 | ▼ $474,750 |
| Total Liabilities and Net Assets / Fund Balance | $558,333 | $0 | ▼ $558,333 |
Compensation and Service Providers
Board Members and Trustees
| Name | Title |
|---|---|
| Steve Silverstein | Chairman & President |
| Alison Martin | Board Member |
| Jeffrey E Gershenwald Md | Board Member |
| Keith T Flaherty Md | Board Member |
| Michael B Atkins Md | Board Member |
| ZE'EV RONAI PHD | Board Member |
| Anthony T Hendrickson | Treasurer & CFO |
Revenue and Support
Revenue Composition
- Contributions and Grants
- $320,000
- Program Service Revenue
- $0
- Investment Income
- $0
- Other Revenue
- $0
- All Other Contributions
- $320,000
- Change in Net Assets
- $5,179
Expenses and Functional Allocation
Major Expense Lines
| Line Item | Amount |
|---|---|
| Grants and Similar Amounts Paid | $300,000 |
| Other Expenses | $14,821 |
| Professional Fundraising Fees | $0 |
| Salaries, Compensation, and Employee Benefits | $0 |
| Total Fundraising Expense | $0 |
Functional Expense Allocation
| Line Item | Program | Management | Fundraising | Total |
|---|---|---|---|---|
| Grants to Domestic Orgs | $300,000 | - | - | $300,000 |
| Fees for Services Other | $12,789 | - | - | $12,789 |
| Fees for Services Accounting | - | $1,545 | - | $1,545 |
| Other Expenses | - | $487 | - | $487 |
| Total Functional Expenses | $312,789 | $2,032 | $0 | $314,821 |
International Activity
Grant and Assistance Recipients
| Recipient | Location | Category | Purpose | Amount |
|---|---|---|---|---|
| University of Pittsburgh | Pittsburgh, PA | 501(c)(3) | Research | $300,000 |
Fundraising, Events, and Gaming
- Fundraising activities
- No
- Gaming activities
- No
- Professional fundraiser used
- No
Fundraising and Gaming Totals
| Line Item | Amount |
|---|---|
| Professional Fundraising Fees | $0 |
Political and Lobbying Activity
- Political campaign activity
- No
- Lobbying activity
- No
- Subject to proxy tax
- No
Insider Transactions and Loans
Loans and Receivables
| Line Item | Beginning | End | Change |
|---|---|---|---|
| Receivables from Disqualified Persons | - | $0 | - |
| Receivables from Officers, Directors, Trustees, and Key Employees | - | $0 | - |
Governance and Compliance
Governance Checklist
- Compiled or reviewed by an accountant
- No
- Annual disclosure for covered persons
- Yes
- Backup withholding compliance
- Yes
- Business relationship with 35% controlled entity
- No
- Business relationship with family members
- No
- Business relationship with organization members
- No
- Material changes to governing documents
- No
- Compensation from other sources disclosed
- No
- CEO compensation reviewed
- No
- Other officer compensation reviewed
- No
- Conflict-of-interest policy
- Yes
- Audited financial statements prepared
- No
- Key decisions subject to board approval
- Yes
- Management duties delegated
- No
Governance Explanations
Form 990, Part VI, Section A, Line 6
“The consortium has one class of members. The qualifications and eligibility for membership and the manner of admission into membership shall be prescribed by resolution of the board of directors and/or by any similarly prescribed rules and regulations which the board of directors may promulgate.”
Form 990, Part VI, Section A, Line 7A
“Each membership shall entitle the holder thereof to one vote in all matters which are required or permitted to be submitted to the membership, including the election or appointment of the board of directors of the consortium.”
Form 990, Part VI, Section A, Line 7B
“Each membership shall entitle the holder thereof to one vote in all matters which are required or permitted to be submitted to the membership, including the election or appointment of the board of directors of the consortium.”
Form 990, Part VI, Section B, Line 11B
“The consortium hires an independent accounting firm to prepare the federal form 990. Upon submission of the final draft 990, the board of directors reviews and approves prior to filing with the internal revenue service.”
Form 990, Part VI, Section B, Line 12C
“Full disclosure, by notice in writing, shall be made by the interested parties to the full board of directors with respect to all conflicts of interest. Following full disclosure of a potential conflict, the board of directors will determine if a conflict exists. Should a conflict exist, that interested person will not participate in any discussion or vote on the matter.”
Form 990, Part VI, Section C, Line 19
“The governing documents, conflicts of interest policy, and financial statements are available to the public upon request.”
Filing and Contact Details
Filer
- Filer Name
- Melanoma Research Foundation
- EIN
- 80-0671049
- Phone
- 2023479675
- Address
- 1420 K STREET NW 7TH FLOOR, WASHINGTON, DC 20005
Signing Officer
- Name
- Anthony T Hendrickson
- Title
- Treasurer & CFO
- Phone
- 2023479675
- Signed
- 2022-01-24
- Discuss with paid preparer
- Yes
Organization Details
- Principal Officer
- Anthony T Hendrickson
- Formed
- 2010
- Legal Domicile
- Dc
- Voting Board Members
- 7
- Independent Board Members
- 7
- Employees
- 0
- Volunteers
- 7
Preparer
- Firm
- Marcum Llp
- Address
- 1899 L STREET NW SUITE 850, WASHINGTON, DC 20036
- Preparer
- Frank H Smith
- Phone
- 2022274000
Supplemental Narrative
Additional Explanations
FORM 990, PART XI, LINE 9:
“Decrease in net assets due to merger -474,750. Other changes in net assets -5,179.”
PAGE 1, BOX B, FINAL RETURN/TERMINATED:
“The melanoma research breakthrough consortium (mrfbc) was dissolved as a separate 501c3 and the program was incorporated within the melanoma research foundation's programmatic offerings. The mrfbc remains a current and vital component of the mrf's scientific and research program.”
Raw XML AppendixShowing 400 of 445 raw XML fields
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990/AccountantCompileOrReviewInd | 0 | 0 |
| IRS990/AccountsPayableAccrExpnssGrp/BOYAmt | 0 | 8583 |
| IRS990/AccountsPayableAccrExpnssGrp/EOYAmt | 0 | 0 |
| IRS990/AccountsReceivableGrp/EOYAmt | 0 | 0 |
| IRS990/ActivitiesConductedPrtshpInd | 0 | 0 |
| IRS990/ActivityOrMissionDesc | 0 | SUPPORTS CLINICAL TRIALS, DRUG DEVELOP. & RESEARCH RELATING TO TREATMENT & PREVENTION OF MELANOMA. |
| IRS990/AllOtherContributionsAmt | 0 | 320000 |
| IRS990/AnnualDisclosureCoveredPrsnInd | 0 | 1 |
| IRS990/BackupWthldComplianceInd | 0 | 1 |
| IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt | 0 | ANTHONY T HENDRICKSON |
| IRS990/BooksInCareOfDetail/PhoneNum | 0 | 2023479675 |
| IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 1420 K STREET NW 7TH FLOOR |
| IRS990/BooksInCareOfDetail/USAddress/CityNm | 0 | WASHINGTON |
| IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | DC |
| IRS990/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 20005 |
| IRS990/BusinessRlnWith35CtrlEntInd | 0 | 0 |
| IRS990/BusinessRlnWithFamMemInd | 0 | 0 |
| IRS990/BusinessRlnWithOrgMemInd | 0 | 0 |
| IRS990/CashNonInterestBearingGrp/BOYAmt | 0 | 508321 |
| IRS990/CashNonInterestBearingGrp/EOYAmt | 0 | 0 |
| IRS990/ChangeToOrgDocumentsInd | 0 | 0 |
| IRS990/CntrctRcvdGreaterThan100KCnt | 0 | 0 |
| IRS990/CollectionsOfArtInd | 0 | 0 |
| IRS990/CompensationFromOtherSrcsInd | 0 | 0 |
| IRS990/CompensationProcessCEOInd | 0 | 0 |
| IRS990/CompensationProcessOtherInd | 0 | 0 |
| IRS990/ConflictOfInterestPolicyInd | 0 | 1 |
| IRS990/ConservationEasementsInd | 0 | 0 |
| IRS990/ConsolidatedAuditFinclStmtInd | 0 | 0 |
| IRS990/ContractTerminationInd | 0 | X |
| IRS990/CreditCounselingInd | 0 | 0 |
| IRS990/CYBenefitsPaidToMembersAmt | 0 | 0 |
| IRS990/CYContributionsGrantsAmt | 0 | 320000 |
| IRS990/CYGrantsAndSimilarPaidAmt | 0 | 300000 |
| IRS990/CYInvestmentIncomeAmt | 0 | 0 |
| IRS990/CYOtherExpensesAmt | 0 | 14821 |
| IRS990/CYOtherRevenueAmt | 0 | 0 |
| IRS990/CYProgramServiceRevenueAmt | 0 | 0 |
| IRS990/CYRevenuesLessExpensesAmt | 0 | 5179 |
| IRS990/CYSalariesCompEmpBnftPaidAmt | 0 | 0 |
| IRS990/CYTotalExpensesAmt | 0 | 314821 |
| IRS990/CYTotalFundraisingExpenseAmt | 0 | 0 |
| IRS990/CYTotalProfFndrsngExpnsAmt | 0 | 0 |
| IRS990/CYTotalRevenueAmt | 0 | 320000 |
| IRS990/DecisionsSubjectToApprovaInd | 0 | 1 |
| IRS990/DeductibleArtContributionInd | 0 | 0 |
| IRS990/DeductibleNonCashContriInd | 0 | 0 |
| IRS990/DelegationOfMgmtDutiesInd | 0 | 0 |
| IRS990/Desc | 0 | THE CONSORTIUM SEEKS TO ACCELERATE RESEARCH AND DEVELOPMENT OF THE MOST PROMISING THERAPEUTICS IN MELANOMA IN ORDER TO DELIVER CURATIVE OPTIONS TO PATIENTS. SUCCESS IN THIS ENDEAVOR ALSO FURTHERS THE EXEMPT PURPOSE OF THE MELANOMA RESEARCH FOUNDATION (MRF). IN ORDER TO ACHIEVE ITS MISSION, THE CONSORTIUM WILL DEVELOP COLLABORATIVE, MULTI-SECTOR PARTNERSHIPS ACROSS THE BREADTH OF MELANOMA DISCIPLINES- BASIC, TRANSLATIONAL AND CLINICAL SCIENCE- TO EXPEDITE DEVELOPMENT OF COMBINATION THERAPIES AS WELL AS NOVEL SINGLE AGENTS; SUPPORT PRECLINICAL RESEARCH TO FACILITATE RATIONAL COMBINATIONS; CREATE A VIRTUAL ANNOTATED SPECIMEN BIOREPOSITORY; AND IDENTIFY BIOMARKERS THAT HAVE PROGNOSTIC AND PREDICTIVE VALUE OR VALUE AS NEW THERAPEUTIC TARGETS WHICH REQUIRED THE EXPERTISE OF A MD AND PROJECT MANAGER. IN ADDITION, THE CONSORTIUM'S BOARD OF DIRECTORS AND PARTICIPATING RESEARCH INSTITUTIONS WILL CONDUCT OUTREACH TO MULTI SECTOR PARTNERS WITH AN INTEREST OR INVESTMENT IN MELANOMA RESEARCH TO ENSURE THAT THE CONSORTIUM IS AWARE OF ANY IMPORTANT DEVELOPMENTS OR PROMISING RESEARCH IN THE FIELD OF MELANOMA. |
| IRS990/DescribedInSection501c3Ind | 0 | 1 |
| IRS990/DisregardedEntityInd | 0 | 0 |
| IRS990/DocumentRetentionPolicyInd | 0 | 1 |
| IRS990/DonorAdvisedFundInd | 0 | 0 |
| IRS990/DonorRestrictionNetAssetsGrp/BOYAmt | 0 | 400150 |
| IRS990/DonorRestrictionNetAssetsGrp/EOYAmt | 0 | 0 |
| IRS990/DonorRstrOrQuasiEndowmentsInd | 0 | 0 |
| IRS990/ElectionOfBoardMembersInd | 0 | 1 |
| IRS990/EmployeeCnt | 0 | 0 |
| IRS990/EngagedInExcessBenefitTransInd | 0 | 0 |
| IRS990/ExpenseAmt | 0 | 312789 |
| IRS990/FamilyOrBusinessRlnInd | 0 | 0 |
| IRS990/FederalGrantAuditRequiredInd | 0 | 0 |
| IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt | 0 | 1545 |
| IRS990/FeesForServicesAccountingGrp/TotalAmt | 0 | 1545 |
| IRS990/FeesForServicesOtherGrp/ProgramServicesAmt | 0 | 12789 |
| IRS990/FeesForServicesOtherGrp/TotalAmt | 0 | 12789 |
| IRS990/FinalReturnInd | 0 | X |
| IRS990/ForeignActivitiesInd | 0 | 0 |
| IRS990/ForeignFinancialAccountInd | 0 | 0 |
| IRS990/ForeignOfficeInd | 0 | 0 |
| IRS990/Form8282PropertyDisposedOfInd | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt | 0 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt | 1 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt | 2 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 0 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 1 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 2 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 3 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 4 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 5 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 6 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 3 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 4 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 5 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 6 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 6 | 0 |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 0 | STEVE SILVERSTEIN |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 1 | ANTHONY T HENDRICKSON |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 2 | MICHAEL B ATKINS MD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 3 | KEITH T FLAHERTY MD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 4 | JEFFREY E GERSHENWALD MD |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 5 | ALISON MARTIN |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 6 | ZE'EV RONAI PHD |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 6 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 0 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 1 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 2 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 3 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 4 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 6 | 0 |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 0 | CHAIRMAN & PRESIDENT |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 1 | TREASURER & CFO |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 2 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 3 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 4 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 5 | BOARD MEMBER |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 6 | BOARD MEMBER |
| IRS990/Form990ProvidedToGvrnBodyInd | 0 | 1 |
| IRS990/FormationYr | 0 | 2010 |
| IRS990/FormerOfcrEmployeesListedInd | 0 | 0 |
| IRS990/FSAuditedInd | 0 | 0 |
| IRS990/FundraisingActivitiesInd | 0 | 0 |
| IRS990/GamingActivitiesInd | 0 | 0 |
| IRS990/GoverningBodyVotingMembersCnt | 0 | 7 |
| IRS990/GrantAmt | 0 | 300000 |
| IRS990/GrantsPayableGrp/BOYAmt | 0 | 75000 |
| IRS990/GrantsPayableGrp/EOYAmt | 0 | 0 |
| IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt | 0 | 300000 |
| IRS990/GrantsToDomesticOrgsGrp/TotalAmt | 0 | 300000 |
| IRS990/GrantsToIndividualsInd | 0 | 0 |
| IRS990/GrantsToOrganizationsInd | 0 | 1 |
| IRS990/GrantToRelatedPersonInd | 0 | 0 |
| IRS990/GrossReceiptsAmt | 0 | 320000 |
| IRS990/GroupReturnForAffiliatesInd | 0 | 0 |
| IRS990/IncludeFIN48FootnoteInd | 0 | 0 |
| IRS990/IndependentAuditFinclStmtInd | 0 | 0 |
| IRS990/IndependentVotingMemberCnt | 0 | 7 |
| IRS990/IndivRcvdGreaterThan100KCnt | 0 | 0 |
| IRS990/IndoorTanningServicesInd | 0 | 0 |
| IRS990/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990/InfoInScheduleOPartVIInd | 0 | X |
| IRS990/InfoInScheduleOPartXIInd | 0 | X |
| IRS990/IntangibleAssetsGrp/EOYAmt | 0 | 0 |
| IRS990/InventoriesForSaleOrUseGrp/EOYAmt | 0 | 0 |
| IRS990/InvestmentInJointVentureInd | 0 | 0 |
| IRS990/InvestmentsOtherSecuritiesGrp/EOYAmt | 0 | 0 |
| IRS990/InvestmentsProgramRelatedGrp/EOYAmt | 0 | 0 |
| IRS990/InvestmentsPubTradedSecGrp/EOYAmt | 0 | 0 |
| IRS990/IRPDocumentCnt | 0 | 1 |
| IRS990/IRPDocumentW2GCnt | 0 | 0 |
| IRS990/LandBldgEquipBasisNetGrp/EOYAmt | 0 | 0 |
| IRS990/LegalDomicileStateCd | 0 | DC |
| IRS990/LoanOutstandingInd | 0 | 0 |
| IRS990/LobbyingActivitiesInd | 0 | 0 |
| IRS990/LocalChaptersInd | 0 | 0 |
| IRS990/MaterialDiversionOrMisuseInd | 0 | 0 |
| IRS990/MembersOrStockholdersInd | 0 | 1 |
| IRS990/MethodOfAccountingAccrualInd | 0 | X |
| IRS990/MinutesOfCommitteesInd | 0 | 1 |
| IRS990/MinutesOfGoverningBodyInd | 0 | 1 |
| IRS990/MissionDesc | 0 | THE MISSION OF THE MELANOMA RESEARCH FOUNDATION BREAKTHROUGH CONSORTIUM, INC. (THE CONSORTIUM) IS TO ACCELERATE THE RESEARCH AND DEVELOPMENT OF THE MOST PROMISING THERAPEUTICS IN MELANOMA IN ORDER TO DELIVER CURATIVE OPTIONS TO PATIENTS. THE CONSORTIUM WILL DEVELOP COLLABORATIVE, MULTI-SECTOR PARTNERSHIPS ACROSS THE BREADTH OF MELANOMA DISCIPLINES - BASIC, TRANSLATIONAL AND CLINICAL SCIENCE - TO EXPEDITE DEVELOPMENT OF COMBINATIONS OF THERAPIES AS WELL AS NOVEL SINGLE AGENTS; SUPPORT PRE-CLINICAL RESEARCH TO FACILITATE RATIONAL COMBINATIONS; CREATE A VIRTUAL ANNOTATED SPECIMEN BIOREPOSITORY; AND IDENTIFY BIOMARKERS THAT HAVE PROGNOSTIC AND PREDICTIVE VALUE OR VALUE AS A NEW THERAPEUTIC TARGET. |
| IRS990/MoreThan5000KToIndividualsInd | 0 | 0 |
| IRS990/MoreThan5000KToOrgInd | 0 | 0 |
| IRS990/NetAssetsOrFundBalancesBOYAmt | 0 | 474750 |
| IRS990/NetAssetsOrFundBalancesEOYAmt | 0 | 0 |
| IRS990/NetUnrelatedBusTxblIncmAmt | 0 | 0 |
| IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt | 0 | 74600 |
| IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt | 0 | 0 |
| IRS990/NoListedPersonsCompensatedInd | 0 | X |
| IRS990/NondeductibleContributionsInd | 0 | 0 |
| IRS990/OfficerMailingAddressInd | 0 | 0 |
| IRS990/OperateHospitalInd | 0 | 0 |
| IRS990/Organization501c3Ind | 0 | X |
| IRS990/OrganizationFollowsFASB117Ind | 0 | X |
| IRS990/OtherAssetsTotalGrp/BOYAmt | 0 | 20534 |
| IRS990/OtherAssetsTotalGrp/EOYAmt | 0 | 0 |
| IRS990/OtherChangesInNetAssetsAmt | 0 | -479929 |
| IRS990/OtherExpensesGrp/Desc | 0 | REGISTRATION FEES |
| IRS990/OtherExpensesGrp/ManagementAndGeneralAmt | 0 | 487 |
| IRS990/OtherExpensesGrp/TotalAmt | 0 | 487 |
| IRS990/OthNotesLoansReceivableNetGrp/EOYAmt | 0 | 0 |
| IRS990/PartialLiquidationInd | 0 | 0 |
| IRS990/PayPremiumsPrsnlBnftCntrctInd | 0 | 0 |
| IRS990/PledgesAndGrantsReceivableGrp/EOYAmt | 0 | 0 |
| IRS990/PoliticalCampaignActyInd | 0 | 0 |
| IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt | 0 | 29478 |
| IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt | 0 | 0 |
| IRS990/PrincipalOfficerNm | 0 | ANTHONY T HENDRICKSON |
| IRS990/ProfessionalFundraisingInd | 0 | 0 |
| IRS990/ProhibitedTaxShelterTransInd | 0 | 0 |
| IRS990/PYBenefitsPaidToMembersAmt | 0 | 0 |
| IRS990/PYContributionsGrantsAmt | 0 | 390534 |
| IRS990/PYExcessBenefitTransInd | 0 | 0 |
| IRS990/PYGrantsAndSimilarPaidAmt | 0 | 300000 |
| IRS990/PYInvestmentIncomeAmt | 0 | 0 |
| IRS990/PYOtherExpensesAmt | 0 | 79543 |
| IRS990/PYOtherRevenueAmt | 0 | 0 |
| IRS990/PYProgramServiceRevenueAmt | 0 | 0 |
| IRS990/PYRevenuesLessExpensesAmt | 0 | 10991 |
| IRS990/PYSalariesCompEmpBnftPaidAmt | 0 | 0 |
| IRS990/PYTotalExpensesAmt | 0 | 379543 |
| IRS990/PYTotalProfFndrsngExpnsAmt | 0 | 0 |
| IRS990/PYTotalRevenueAmt | 0 | 390534 |
| IRS990/QuidProQuoContributionsInd | 0 | 0 |
| IRS990/RcvblFromDisqualifiedPrsnGrp/EOYAmt | 0 | 0 |
| IRS990/RcvFndsToPayPrsnlBnftCntrctInd | 0 | 0 |
| IRS990/ReceivablesFromOfficersEtcGrp/EOYAmt | 0 | 0 |
| IRS990/ReconcilationRevenueExpnssAmt | 0 | 5179 |
| IRS990/RegularMonitoringEnfrcInd | 0 | 1 |
| IRS990/RelatedEntityInd | 0 | 1 |
| IRS990/RelatedOrganizationCtrlEntInd | 0 | 0 |
| IRS990/ReportInvestmentsOtherSecInd | 0 | 0 |
| IRS990/ReportLandBuildingEquipmentInd | 0 | 0 |
| IRS990/ReportOtherAssetsInd | 0 | 0 |
| IRS990/ReportOtherLiabilitiesInd | 0 | 0 |
| IRS990/ReportProgramRelatedInvstInd | 0 | 0 |
| IRS990/SavingsAndTempCashInvstGrp/EOYAmt | 0 | 0 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/Contribution35ControlledInd | 0 | 0 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionControllerInd | 0 | 0 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionFamilyInd | 0 | 0 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/ControlledDisqualifiedPrsnInd | 0 | 0 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnControllIntInd | 0 | 0 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnOwnrIntInd | 0 | 0 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/ExcessBusinessHoldingsRulesInd | 0 | 0 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/ListedByNameGoverningDocInd | 0 | 1 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/LoanDisqualifiedPersonInd | 0 | 0 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/OrganizationChangeSuprtOrgInd | 0 | 0 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/PaymentSubstantialContribtrInd | 0 | 0 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgNotOrganizedUSInd | 0 | 0 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgSectionC456Ind | 0 | 0 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportNonSupportedOrgInd | 0 | 0 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/SuprtOrgNoIRSDeterminationInd | 0 | 0 |
| IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/OperateBenefitNonSuprtOrgInd | 0 | 0 |
| IRS990ScheduleA/Form990SchAType1SuprtOrgGrp/PowerAppointMajorityDirTrstInd | 0 | 1 |
| IRS990ScheduleA/OtherSupportSumAmt | 0 | 0 |
| IRS990ScheduleA/SupportedOrganizationsCnt | 0 | 1 |
| IRS990ScheduleA/SupportedOrganizationsTotalCnt | 0 | 1 |
| IRS990ScheduleA/SupportedOrgInformationGrp/EIN | 0 | 760514428 |
| IRS990ScheduleA/SupportedOrgInformationGrp/GoverningDocumentListedInd | 0 | 1 |
| IRS990ScheduleA/SupportedOrgInformationGrp/OrganizationTypeCd | 0 | 7 |
| IRS990ScheduleA/SupportedOrgInformationGrp/OtherSupportAmt | 0 | 0 |
| IRS990ScheduleA/SupportedOrgInformationGrp/SupportAmt | 0 | 0 |
| IRS990ScheduleA/SupportedOrgInformationGrp/SupportedOrganizationName/BusinessNameLine1Txt | 0 | MELANOMA RESEARCH FOUNDATION |
| IRS990ScheduleA/SupportingOrganization509a3Ind | 0 | X |
| IRS990ScheduleA/SupportingOrgType1Ind | 0 | X |
| IRS990ScheduleA/SupportSumAmt | 0 | 0 |
| IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorNum | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine2 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt | 0 | RESTRICTED |
| IRS990/ScheduleBRequiredInd | 0 | 1 |
| IRS990ScheduleI/GrantRecordsMaintainedInd | 0 | 1 |
| IRS990ScheduleI/RecipientTable/CashGrantAmt | 0 | 300000 |
| IRS990ScheduleI/RecipientTable/IRCSectionDesc | 0 | 501(C)(3) |
| IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt | 0 | RESEARCH |
| IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt | 0 | UNIVERSITY OF PITTSBURGH |
| IRS990ScheduleI/RecipientTable/RecipientEIN | 0 | 250965591 |
| IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt | 0 | 500 ROSS STREET SUITE 154-0455 |
| IRS990ScheduleI/RecipientTable/USAddress/CityNm | 0 | PITTSBURGH |
| IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd | 0 | PA |
| IRS990ScheduleI/RecipientTable/USAddress/ZIPCd | 0 | 152620001 |
| IRS990ScheduleI/SupplementalInformationDetail/ExplanationTxt | 0 | THE CONSORTIUM'S GRANT IS CONDUCTED IN A FAIR AND OPEN PROCESS, WITH STATED ELIGIBILITY CRITERIA THAT CONTROL COI AND IMPACT AND FEASIBILITY OF THE PROPOSED RESEARCH. IT IS REVIEWED BY A PEER REVIEWED COMMITTEE THAT IS CONTROLLED FOR COI, WITH GRANTS RANKED AND SCORED. THE GRANT ADMINISTRATION OF THE CONSORTIUM MONITORS THE PROGRESS, RESULTS AND FINANCES THROUGH PROGRESS REPORTS AND SURVEYS OF ROI. AWARDEES WILL BE EXPECTED TO PROVIDE STATUS UPDATES AT THE CONSORTIUM'S BI-ANNUAL MEETINGS. IN ADDITION, INTERIM FINANCIAL AND SCIENTIFIC PROGRESS REPORTS ARE TO BE SUBMITTED TO THE MRF NO LATER THAN 30 DAYS PRIOR TO THE END OF YEAR ONE. FINAL FINANCIAL AND SCIENTIFIC REPORTS, DETAILING ALL ACTIVITIES DURING THE AWARD PERIOD ARE TO BE SUBMITTED TO THE MRF WITHIN 60 DAYS OF THE END OF THE AWARD PERIOD. THE REPORT FORM REQUESTS SUMMARIES AND OUTCOMES ON THE RESEARCH, PRESENTATIONS, PUBLICATIONS, PATENTS, CLINICAL TRIALS, NEW COLLABORATIONS, AND/OR NEW RESEARCH FUNDING PURSUANT TO THE PROPOSED RESEARCH. ACKNOWLEDGMENT OF SUPPORT FROM THE MRF & BMS MUST ACCOMPANY ANY PUBLISHED REPORT USING DATA OR FINDINGS FROM RESEARCH CONDUCTED UNDER THIS AWARD. |
| IRS990ScheduleI/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | PART I, LINE 2: |
| IRS990ScheduleI/Total501c3OrgCnt | 0 | 1 |
| IRS990ScheduleI/TotalOtherOrgCnt | 0 | 0 |
| IRS990/ScheduleJRequiredInd | 0 | 0 |
| IRS990ScheduleN/AssetsDistributedInd | 0 | 1 |
| IRS990ScheduleN/AttorneyGeneralNotifiedInd | 0 | 1 |
| IRS990ScheduleN/BondsOutstandingInd | 0 | 0 |
| IRS990ScheduleN/DirectorOfSuccessorInd | 0 | 1 |
| IRS990ScheduleN/EmployeeOfSuccessorInd | 0 | 0 |
| IRS990ScheduleN/LiabilitiesPaidInd | 0 | 1 |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/AssetsDistriOrExpnssPaidDesc | 0 | NET ASSETS |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/AssetsDistriOrExpnssPaidDesc | 1 | NET INCOME |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/BusinessName/BusinessNameLine1Txt | 0 | MELANOMA RESEARCH FOUNDATION |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/BusinessName/BusinessNameLine1Txt | 1 | MELANOMA RESEARCH FOUNDATION |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/DistributionDt | 0 | 2021-03-22 |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/DistributionDt | 1 | 2021-03-22 |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/EIN | 0 | 760514428 |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/EIN | 1 | 760514428 |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/FairMarketValueOfAssetAmt | 0 | 474750 |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/FairMarketValueOfAssetAmt | 1 | 5129 |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/IRCSectionTxt | 0 | 501(C)(3) |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/IRCSectionTxt | 1 | 501(C)(3) |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/MethodOfFMVDeterminationTxt | 0 | BOOK VALUE |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/MethodOfFMVDeterminationTxt | 1 | BOOK VALUE |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/AddressLine1Txt | 0 | 1420 K STREET NW 7TH FLOOR |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/AddressLine1Txt | 1 | 1420 K STREET NW 7TH FLOOR |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/CityNm | 0 | WASHINGTON |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/CityNm | 1 | WASHINGTON |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/StateAbbreviationCd | 0 | DC |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/StateAbbreviationCd | 1 | DC |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/ZIPCd | 0 | 20005 |
| IRS990ScheduleN/LiquidationOfAssetsTableGrp/LiquidationOfAssetsDetail/USAddress/ZIPCd | 1 | 20005 |
| IRS990ScheduleN/OwnerOfSuccessorInd | 0 | 0 |
| IRS990ScheduleN/ReceiveCompensationInd | 0 | 0 |
| IRS990ScheduleN/RequiredToNotifyAGInd | 0 | 1 |
| IRS990ScheduleN/SupplementalInformationDetail/ExplanationTxt | 0 | PERSON(S) INVOLVED: STEVE SILVERSTEIN, ANTHONY T. HENDRICKSON, MICHAEL B. ATKINS, MD, AND ALISON MARTIN. |
| IRS990ScheduleN/SupplementalInformationDetail/ExplanationTxt | 1 | EXPLANATION OF INVOLVEMENT: STEVE SILVERSTEIN, CHAIRANTHONY T. HENDRICKSON, BOARD MEMBERMICHAEL B. ATKINS, MD, BOARD MEMBERALISON MARTIN, BOARD MEMBER |
| IRS990ScheduleN/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | PART I, LINE 2E: |
| IRS990ScheduleN/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | PART I, LINE 2E: |
| IRS990/ScheduleORequiredInd | 0 | 1 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | THE CONSORTIUM HAS ONE CLASS OF MEMBERS. THE QUALIFICATIONS AND ELIGIBILITY FOR MEMBERSHIP AND THE MANNER OF ADMISSION INTO MEMBERSHIP SHALL BE PRESCRIBED BY RESOLUTION OF THE BOARD OF DIRECTORS AND/OR BY ANY SIMILARLY PRESCRIBED RULES AND REGULATIONS WHICH THE BOARD OF DIRECTORS MAY PROMULGATE. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | EACH MEMBERSHIP SHALL ENTITLE THE HOLDER THEREOF TO ONE VOTE IN ALL MATTERS WHICH ARE REQUIRED OR PERMITTED TO BE SUBMITTED TO THE MEMBERSHIP, INCLUDING THE ELECTION OR APPOINTMENT OF THE BOARD OF DIRECTORS OF THE CONSORTIUM. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | EACH MEMBERSHIP SHALL ENTITLE THE HOLDER THEREOF TO ONE VOTE IN ALL MATTERS WHICH ARE REQUIRED OR PERMITTED TO BE SUBMITTED TO THE MEMBERSHIP, INCLUDING THE ELECTION OR APPOINTMENT OF THE BOARD OF DIRECTORS OF THE CONSORTIUM. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | THE CONSORTIUM HIRES AN INDEPENDENT ACCOUNTING FIRM TO PREPARE THE FEDERAL FORM 990. UPON SUBMISSION OF THE FINAL DRAFT 990, THE BOARD OF DIRECTORS REVIEWS AND APPROVES PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 4 | FULL DISCLOSURE, BY NOTICE IN WRITING, SHALL BE MADE BY THE INTERESTED PARTIES TO THE FULL BOARD OF DIRECTORS WITH RESPECT TO ALL CONFLICTS OF INTEREST. FOLLOWING FULL DISCLOSURE OF A POTENTIAL CONFLICT, THE BOARD OF DIRECTORS WILL DETERMINE IF A CONFLICT EXISTS. SHOULD A CONFLICT EXIST, THAT INTERESTED PERSON WILL NOT PARTICIPATE IN ANY DISCUSSION OR VOTE ON THE MATTER. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 5 | THE GOVERNING DOCUMENTS, CONFLICTS OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 6 | DECREASE IN NET ASSETS DUE TO MERGER -474,750. OTHER CHANGES IN NET ASSETS -5,179. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 7 | THE MELANOMA RESEARCH BREAKTHROUGH CONSORTIUM (MRFBC) WAS DISSOLVED AS A SEPARATE 501C3 AND THE PROGRAM WAS INCORPORATED WITHIN THE MELANOMA RESEARCH FOUNDATION'S PROGRAMMATIC OFFERINGS. THE MRFBC REMAINS A CURRENT AND VITAL COMPONENT OF THE MRF'S SCIENTIFIC AND RESEARCH PROGRAM. |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990, PART VI, SECTION A, LINE 6 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990, PART VI, SECTION A, LINE 7A |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990, PART VI, SECTION A, LINE 7B |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | FORM 990, PART VI, SECTION B, LINE 11B |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 4 | FORM 990, PART VI, SECTION B, LINE 12C |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 5 | FORM 990, PART VI, SECTION C, LINE 19 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 6 | FORM 990, PART XI, LINE 9: |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 7 | PAGE 1, BOX B, FINAL RETURN/TERMINATED: |
| IRS990ScheduleR/AssetExchangeInd | 0 | 0 |
| IRS990ScheduleR/AssetPurchaseFromOtherOrgInd | 0 | 0 |
| IRS990ScheduleR/AssetSaleToOtherOrgInd | 0 | 0 |
| IRS990ScheduleR/DivRelatedOrganizationInd | 0 | 0 |
| IRS990ScheduleR/GiftGrntCapContriFromOthOrgInd | 0 | 0 |
| IRS990ScheduleR/GiftGrntOrCapContriToOthOrgInd | 0 | 0 |
| IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/ControlledOrganizationInd | 0 | 0 |
| IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/DirectControllingNACd | 0 | N/A |
| IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/DisregardedEntityName/BusinessNameLine1Txt | 0 | MELANOMA RESEARCH FOUNDATION |
| IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/EIN | 0 | 760514428 |
| IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/ExemptCodeSectionTxt | 0 | 501(C)(3) |
| IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/LegalDomicileStateCd | 0 | TX |
| IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/PrimaryActivitiesTxt | 0 | RESEARCH, AWARENESS AND ADVOCACY FOR MELANOMA |
| IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/PublicCharityStatusTxt | 0 | LINE 7 |
| IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/AddressLine1Txt | 0 | 1420 K STREET NW 7TH FLOOR |
| IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/CityNm | 0 | WASHINGTON |
| IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/StateAbbreviationCd | 0 | DC |
| IRS990ScheduleR/IdRelatedTaxExemptOrgGrp/USAddress/ZIPCd | 0 | 20005 |
| IRS990ScheduleR/LoansOrGuaranteesFromOthOrgInd | 0 | 0 |
| IRS990ScheduleR/LoansOrGuaranteesToOtherOrgInd | 0 | 0 |
| IRS990ScheduleR/PaidEmployeesSharingInd | 0 | 0 |
| IRS990ScheduleR/PerformOfServicesByOtherOrgInd | 0 | 0 |
| IRS990ScheduleR/PerformOfServicesForOthOrgInd | 0 | 0 |
| IRS990ScheduleR/ReceiptOfIntAnntsRntsRyltsInd | 0 | 0 |
| IRS990ScheduleR/ReimbursementPaidByOtherOrgInd | 0 | 0 |
| IRS990ScheduleR/ReimbursementPaidToOtherOrgInd | 0 | 0 |
| IRS990ScheduleR/RentalOfFacilitiesToOthOrgInd | 0 | 0 |
| IRS990ScheduleR/RentalOfFcltsFromOthOrgInd | 0 | 0 |
| IRS990ScheduleR/SharingOfFacilitiesInd | 0 | 1 |
| IRS990ScheduleR/TransferFromOtherOrgInd | 0 | 0 |
| IRS990ScheduleR/TransferToOtherOrgInd | 0 | 0 |
| IRS990/SchoolOperatingInd | 0 | 0 |
| IRS990/SignificantChangeInd | 0 | 0 |
| IRS990/SignificantNewProgramSrvcInd | 0 | 0 |
| IRS990/SubjectToExcsTaxNetInvstIncInd | 0 | 0 |
| IRS990/SubjectToProxyTaxInd | 0 | 0 |
| IRS990/SubjToTaxRmnrtnExPrchtPymtInd | 0 | 0 |
| IRS990/TaxablePartyNotificationInd | 0 | 0 |
| IRS990/TaxExemptBondsInd | 0 | 0 |
| IRS990/TerminateOperationsInd | 0 | 1 |
| IRS990/TotalAssetsBOYAmt | 0 | 558333 |
| IRS990/TotalAssetsEOYAmt | 0 | 0 |
| IRS990/TotalAssetsGrp/BOYAmt | 0 | 558333 |
| IRS990/TotalAssetsGrp/EOYAmt | 0 | 0 |
| IRS990/TotalCompGreaterThan150KInd | 0 | 0 |
| IRS990/TotalContributionsAmt | 0 | 320000 |
| IRS990/TotalEmployeeCnt | 0 | 0 |
| IRS990/TotalFunctionalExpensesGrp/FundraisingAmt | 0 | 0 |
| IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt | 0 | 2032 |
| IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt | 0 | 312789 |
| IRS990/TotalFunctionalExpensesGrp/TotalAmt | 0 | 314821 |
| IRS990/TotalGrossUBIAmt | 0 | 0 |
| IRS990/TotalLiabilitiesBOYAmt | 0 | 83583 |
| IRS990/TotalLiabilitiesEOYAmt | 0 | 0 |
| IRS990/TotalLiabilitiesGrp/BOYAmt | 0 | 83583 |
| IRS990/TotalLiabilitiesGrp/EOYAmt | 0 | 0 |
| IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt | 0 | 474750 |
| IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt | 0 | 0 |
| IRS990/TotalOtherCompensationAmt | 0 | 0 |
| IRS990/TotalProgramServiceExpensesAmt | 0 | 312789 |
| IRS990/TotalReportableCompFromOrgAmt | 0 | 0 |
| IRS990/TotalRevenueGrp/ExclusionAmt | 0 | 0 |
| IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt | 0 | 0 |
| IRS990/TotalRevenueGrp/TotalRevenueColumnAmt | 0 | 320000 |
| IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt | 0 | 0 |
| IRS990/TotalVolunteersCnt | 0 | 7 |
| IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt | 0 | 558333 |
| IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt | 0 | 0 |
| IRS990/TotReportableCompRltdOrgAmt | 0 | 0 |
| IRS990/TrnsfrExmptNonChrtblRltdOrgInd | 0 | 0 |
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2021 • Form 990Facts available. Structured filing facts are available, but richer extracted sections are limited.
- Assets
- $0
- Liabilities
- $0
- Net assets
- $0
- Revenue
- $320,000
- Expenses
- $314,821
- Net income
- $5,179
Peer Organizations
Similar nonprofits based on the same Siviq industry and scale cohort. 2021 filings • 501(c)3 • <$500k nonprofits
Location unavailable
View OrganizationAenon International
501(c)3
Revenue$80,000
Assets$320,000
Revenue vs current organization
75% lowerAssets vs current organization
No dataKansas City, KS
View OrganizationBd23 Holdings Inc
501(c)3
Revenue-
Assets$320,001
Revenue vs current organization
No dataAssets vs current organization
No dataBay Village, OH
View OrganizationFill This House Inc
501(c)3
Revenue$139,272
Assets$320,017
Revenue vs current organization
56% lowerAssets vs current organization
No dataParamus, NJ
View OrganizationUja-Add Respite Services Inc
501(c)3
Revenue$320,030
Assets$0
Revenue vs current organization
About the sameAssets vs current organization
No data